- $573.52m
- $454.89m
- $418.63m
It Was In Co's Best Interests To Combine Roles Of CFO And Chief Accounting Officer
Brief: Mediwound Announces Collaboration With Mimedx On Escharex Phase III Study
MiMedx Group Inc reports results for the quarter ended in June - Earnings Summary
Brief: MiMedx Q2 Sales USD 81.257 Million Vs. IBES Estimate USD 74.8 Million
MiMedx Group Inc expected to post a loss of 2 cents a share - Earnings Preview
Brief: MIMEDX Announces Favorable Ruling in Putative Securities Class Action Case
Brief: MiMedx Appoints Doug Rice As Chief Financial Officer
Brief: MiMedx Group Says Robert Stein’s Position As President Of Regenerative Medicine Business Unit Eliminated, And He Will Be Departing From The Company
Brief: MIMEDX Announces Strategic Realignment
MiMedx Group Inc reports results for the quarter ended in March - Earnings Summary
Brief: Mimedx Announces First Quarter 2023 Operating And Financial Results
Brief: MiMedx posts Q1 sales of USD 71.676 million
MiMedx Group Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: MiMedx Group Announces Chief Financial Officer Transition
Brief: MiMedx Reports Q4 sales $74.375 Million
Brief: Mimedx Announces Fourth Quarter And Full Year 2022 Operating And Financial Results
MiMedx Group Inc reports results for the quarter ended in December - Earnings Summary
MiMedx Group Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Mimedx Appoints Joseph Capper As CEO And Director